2025-02-25 NaaS Technology Inc. HaiPress
BEIJING,Feb. 24,2025 -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"),the first U.S.-listed EV charging service company in China,today announced that management will participate inthe following upcoming investor conferences in February 2025:
Event:Western Securities Listed Companies Spring Investor Conference
Date: February 25,2025
Place:Shenzhen,China
Organizer:Western Securities
Event:Sealand Securities 2025 Spring Strategy Conference
Date: February 27,2025
Place:Shanghai,China
Organizer:Sealand Securities
Event:GF Securities Listed Companies Spring Investor Conference
Date: February 27,China
Organizer:GF Securities
Connect with NaaS Management
For more information or to schedule a one-on-one meeting with NaaS management,please contact your event representative or NaaS investor relations team via email at ir@enaas.com
About NaaS Technology Inc.
NaaS Technology Inc. is the first U.S. listed EV charging service company in China. The Company is a subsidiary of Newlinks Technology Limited,a leading energy digitalization group in China.The Companyis one of the leading providersof new energy asset operation services. The Company utilizes advancedtechnology to intelligently match charging supply with demand,offering electric vehicle users a seamless,efficient,and smart charging experience. Furthermore,NaaS empowers charging stationsand charging station operators to optimize their operations,driving greater efficiency and enhancing profitability.
For investor and media inquiries,please contact:
Investor Relations
NaaS Technology Inc.
E-mail: ir@enaas.com
Media inquiries:
E-mail: pr@enaas.com
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Diet Tips Daily